Table 3. Unadjusted Logistic Regression Models for Outcome BPD/Mortality at 36 weeks PMA.
| DEMOGRAPHIC VARIABLES | OR (CI) | P value |
|---|---|---|
|
| ||
| Gestational Age | 0.6 (0.5, 0.7) | <0.0001 |
|
| ||
| Birth weight | 0.6 (0.5, 0.8) | <0.0001 |
|
| ||
| Small for Gestational Age (Yes vs No) | 2.6 (0.9, 7.4) | 0.1 |
|
| ||
| Gender (F vs M) | 1.9 (0.6, 2.6) | 0.7 |
|
| ||
| Race | 0.7 | |
| Black vs. White | 1.3 (0.6, 3.0) | |
| Other vs. White | 1.6 (0.3, 7.9) | |
|
| ||
| INTUBATION | OR (CI) | P value |
|
| ||
| Intubation Days 1-4 Yes vs. No | 19.7 (6.7, 57.6) | <0.0001 |
|
| ||
| Maximum biomarker levels (days 1 to 4) | OR (CI) | P value |
|
| ||
| Ln Albumin/Cr | 1.3 (0.9, 1.8) | 0.1 |
|
| ||
| Ln B2M/Cr | 2.6 (1.3, 5.1) | 0.007 |
|
| ||
| Ln CystatinC/Cr | 2.9 (1.9, 4.7) | <0.0001 |
|
| ||
| Ln EGF/Cr | 0.2 (0.07, 0.6) | 0.004 |
|
| ||
| Ln NGAL/Cr | 1.9 (1.3, 2.8) | 0.0009 |
|
| ||
| Ln OPN/Cr | 4.2 (2.2, 8.0) | <0.0001 |
|
| ||
| Ln UMOD/Cr | 0.3 (0.1, 0.7) | 0.006 |
|
| ||
| Ln Clusterin/Cr | 4.9 (2.5, 9.5) | <0.0001 |
|
| ||
| Ln KIM1/Cr | 1.7 (1.1, 2.7) | 0.02 |
|
| ||
| Ln Osteoactivin/Cr | 1.3 (0.6, 2.7) | 0.5 |
|
| ||
| Ln TFF3/Cr | 3.2 (1.7, 5.9) | 0.0002 |
|
| ||
| Ln VEGF/Cr | 2.8 (1.4, 5.6) | 0.005 |
|
| ||
| Ln Calbindin/Cr | 0.8 (0.5, 1.4) | 0.4 |
|
| ||
| Ln α GST/Cr | 1.8 (1.4, 2.3) | <0.0001 |